drugset / Trial / NCT00477503
Nuclear Imaging of Human CSF Flow Using Ga-67 Citrate and In-111 DTPA
Non-randomizedSingle-groupOpen-labelTreatment
Summary
* Primary Objective will be to evaluate the use of Ga-67 citrate as an alternative radiopharmaceutical for CSF imaging. * Secondary Objective will be to evaluate the biodistribution, pharmacokinetics and radiation dosimetry of In 111 DTPA and gallium-67 after intrathecal injection during remission of leptomeningeal metastasis (LM) and during LM occurrence, remission and recurrence.
Timeline
- Start
- 2007-05
- Primary completion
- 2009-07
- Completion
- 2009-07
Outcome
Outcome not reported
Stopped (Enrollment): “One participant enrolled, study terminated .”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Gallium-67 Citrate | Diagnostic / imaging agent | — | Intrathecal |
| Comparator | In-111 DTPA | Diagnostic / imaging agent | — | Intrathecal |